CRESCENDO: ChildREn's muSiC ENhancement in Cochlear Implant Users

计划入组 25 人 · 首次发布于 2025 年 12 月 22 日

The CRESCENDO Program (inCRease Physical Exercise and Sport to Combat ENDOmetriosis)

计划入组 200 人 · 首次发布于 2023 年 4 月 26 日

Herbal Therapy for Treatment of Recurrent Prostate Cancer

计划入组 43 人 · 首次发布于 2008 年 4 月 30 日

CB-401(Crescendo)

CB-201

ROR1 x CD137 x HSA(Crescendo Biologics)

Crescendo Biologics Ltd.

New Zealand

Axcella Health

United States

Astrana Health

United States

Crescendo Health Appoints David Strutton, PhD as Chief Scientific Officer

MEDIPOST Secures $140 Million Funding and Japan Partnership to Advance Stem Cell Therapy for Knee Osteoarthritis

mHealth Intervention Improves Mental Health in Thyroid Cancer Patients